If you’re considering medical weight loss, you may be wondering whether you can use your Health Savings Account (HSA) or Flexible Spending Account (FSA) to help pay for treatment.
The answer depends on your individual plan and the services you receive, but it’s an excellent question to ask before beginning your weight loss journey.
At Pro Health, we’re happy to discuss your treatment plan and provide the information you need as you determine how your healthcare expenses may be covered.
See Also: How Our Pricing Works Without Insurance
Understanding HSAs and FSAs
Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs) allow many individuals to set aside pre-tax dollars for eligible healthcare expenses.
Depending on your plan and the services provided, some medical expenses associated with medically supervised weight loss may qualify.
Some HSA and FSA plans may also require a Letter of Medical Necessity from your healthcare provider before certain weight loss services or treatments are considered eligible for reimbursement. Requirements vary by plan, so it’s important to verify your coverage and documentation requirements with your HSA or FSA administrator before beginning treatment.
Because every HSA and FSA plan is different, it’s important to confirm eligibility before assuming a particular service is covered.
Medical Weight Loss Is More Than Medication
Many patients are surprised to learn that a medically supervised weight loss program involves much more than simply receiving medication.
At Pro Health, every patient begins with a $75 consultation, which includes laboratory testing and a comprehensive evaluation with an experienced nurse practitioner.
During this visit, your provider develops a personalized treatment plan that may include semaglutide, the active ingredient in Ozempic® and Wegovy®, tirzepatide, the active ingredient in Mounjaro® and Zepbound®, phentermine, peptides, lifestyle recommendations, or another medically supervised approach depending on your individual needs.
See Also: Semaglutide vs. Tirzepatide: Understanding Your Medical Weight Loss Options
Questions to Ask Before Using Your HSA or FSA
Before using HSA or FSA funds, consider asking your plan administrator:
- Which medical weight loss services may be eligible?
- Is a Letter of Medical Necessity required?
- Is other documentation required?
- Does my plan require a prescription?
- Which expenses are covered?
Understanding these details before treatment begins can help avoid surprises later.
Transparent Healthcare at Pro Health
One reason patients appreciate Pro Health is our commitment to transparent pricing.
We’ll discuss your treatment plan, explain current pricing, and answer your questions before treatment begins.
Many patients also choose to enroll in one of our memberships, which start at just $30 per month and provide additional value for individuals utilizing ongoing healthcare and wellness services.
See Also: Why Can’t I Lose Weight? Understanding the Factors That May Be Holding You Back
Planning for Your Weight Loss Journey
Medical weight loss is an investment in your long-term health.
Whether you plan to pay out of pocket, utilize HSA or FSA funds when eligible, or take advantage of a Pro Health membership, our goal is to help you understand your options so you can make informed decisions with confidence.
With five convenient Memphis-area clinics, Pro Health is here to answer your questions, explain your treatment options, and help you begin your medically supervised weight loss journey with confidence.
See Also: How Semaglutide Works for Weight Loss: What Memphis Patients Should Know
Important Disclosure
Semaglutide is the active ingredient in Ozempic® and Wegovy®. Tirzepatide is the active ingredient in Mounjaro® and Zepbound®.
Compounded semaglutide and compounded tirzepatide are compounded drug products that have not been approved by the U.S. Food and Drug Administration (FDA); have not been reviewed by the FDA for safety, effectiveness, or quality; and have not been demonstrated to the FDA to be safe or effective for their intended use. The manufacturing processes used to produce compounded medications have not been reviewed by the FDA. FDA-approved products containing semaglutide and tirzepatide are available. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company.